Lipids and lipid mediators associated with the risk and pathology of ischemic stroke
A Kloska, M Malinowska, M Gabig-Cimińska… - International Journal of …, 2020 - mdpi.com
Stroke is a severe neurological disorder in humans that results from an interruption of the
blood supply to the brain. Worldwide, stoke affects over 100 million people each year and is …
blood supply to the brain. Worldwide, stoke affects over 100 million people each year and is …
The beneficial effects of HMG-CoA reductase inhibitors in the processes of neurodegeneration
SS Saeedi Saravi, SS Saeedi Saravi, A Arefidoust… - Metabolic brain …, 2017 - Springer
Statins, cholesterol lowering drugs, have been demonstrated to exert beneficial effects in
other conditions such as primary and progressing neurodegenerative diseases beyond their …
other conditions such as primary and progressing neurodegenerative diseases beyond their …
The benefits and risks of statin therapy in ischemic stroke: a review of the literature
W Zhao, ZJ Xiao, SP Zhao - Neurology India, 2019 - journals.lww.com
Statins are effective cholesterol-lowering drugs for reducing the risks of mortality and
morbidity of cardiovascular diseases. Increasing evidence has shown that statin use is …
morbidity of cardiovascular diseases. Increasing evidence has shown that statin use is …
[HTML][HTML] Effect and safety of rosuvastatin in acute ischemic stroke
Background and Purpose The benefit of statins in acute stroke remains uncertain. Statins
may prevent stroke recurrence during the acute stage of stroke via pleiotropic effects …
may prevent stroke recurrence during the acute stage of stroke via pleiotropic effects …
The efficacy and safety of high-dose statins in acute phase of ischemic stroke and transient ischemic attack: a systematic review
J Fang, E Wang, W Wang, Y Liu, G Cheng - Internal and Emergency …, 2017 - Springer
Inconsistent findings in the studies have been observed concerning the higher dose of
statins use in the acute phase of ischemic stroke and transient ischemic attack (TIA) …
statins use in the acute phase of ischemic stroke and transient ischemic attack (TIA) …
A review on the efficacy and safety of lipid-lowering drugs in neurodegenerative disease
A Rajabian, AP McCloskey, T Jamialahmadi… - Reviews in the …, 2023 - degruyter.com
There is a train of thought that lipid therapies may delay or limit the impact of neuronal loss
and poor patient outcomes of neurodegenerative diseases (NDDs). A variety of medicines …
and poor patient outcomes of neurodegenerative diseases (NDDs). A variety of medicines …
The LDL-receptor and its molecular properties: From theory to novel biochemical and pharmacological approaches in reducing LDL-cholesterol
D Petroglou, I Kanellos, C Savopoulos… - Current Medicinal …, 2020 - ingentaconnect.com
Background: The Low-Density Lipoprotein (LDL) Receptor (LDL-R) is a transmembrane
protein playing a crucial role in effective lipid homeostasis. Various therapeutic agents have …
protein playing a crucial role in effective lipid homeostasis. Various therapeutic agents have …
Low-dose statin pretreatment reduces stroke severity and improves functional outcomes
S Dong, J Guo, J Fang, Y Hong, S Cui, L He - Journal of Neurology, 2019 - Springer
Objectives Pre-stroke statin use reduces stroke severity and improves functional outcomes;
however, whether low-dose statins as a primary preventive measure have similar effects on …
however, whether low-dose statins as a primary preventive measure have similar effects on …
Association of apolipoprotein E genotype with outcome in hospitalized ischemic stroke patients
Y Zhang, S Liu, W Yue, Z Shi, Y Guan, M Li, Y Ji, X Li - Medicine, 2017 - journals.lww.com
Association of apolipoprotein E genotype with outcome in hos... : Medicine Association of
apolipoprotein E genotype with outcome in hospitalized ischemic stroke patients : Medicine Log …
apolipoprotein E genotype with outcome in hospitalized ischemic stroke patients : Medicine Log …
Management of dyslipidaemia for the prevention of stroke: clinical practice recommendations from the Lipid Association of India
R Puri, V Mehta, SS Iyengar… - Current Vascular …, 2022 - ingentaconnect.com
Stroke is the second most common cause of death worldwide. The rates of stroke are
increasing in less affluent countries predominantly because of a high prevalence of …
increasing in less affluent countries predominantly because of a high prevalence of …